<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
    <front>
        <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, USA</publisher-loc>
            </publisher></journal-meta>
        <article-meta><article-id pub-id-type="publisher-id">10-PLGE-RA-NV-4214R2</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1001378</article-id><article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline">
                    <subject>Genetics and Genomics</subject>
                    <subject>Genetics and Genomics/Cancer Genetics</subject>
                    <subject>Genetics and Genomics/Complex Traits</subject>
                    <subject>Genetics and Genomics/Gene Discovery</subject>
                    <subject>Genetics and Genomics/Gene Expression</subject>
                    <subject>Genetics and Genomics/Genetics of Disease</subject>
                    <subject>Genetics and Genomics/Medical Genetics</subject>
                    <subject>Hematology</subject>
                    <subject>Hematology/Lymphomas and Chronic Lymphoblastic Leukemia</subject>
                    <subject>Oncology</subject>
                    <subject>Oncology/Hematological Malignancies</subject>
                    <subject>Oncology/Myelomas and Lymphoproliferative Diseases</subject>
                </subj-group>
            </article-categories><title-group><article-title>GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32
                    and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell
                    Lymphoma</article-title><alt-title alt-title-type="running-head">Allelic Heterogeneity in Follicular
                    Lymphoma GWAS</alt-title></title-group><contrib-group>
                <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
                    <name name-style="western">
                        <surname>Smedby</surname>
                        <given-names>Karin E.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff1">
                        <sup>1</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
                    <name name-style="western">
                        <surname>Foo</surname>
                        <given-names>Jia Nee</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff2">
                        <sup>2</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Skibola</surname>
                        <given-names>Christine F.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff3">
                        <sup>3</sup>
                    </xref>
                    <xref ref-type="fn" rid="fn1">
                        <sup>‡</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Darabi</surname>
                        <given-names>Hatef</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff4">
                        <sup>4</sup>
                    </xref>
                    <xref ref-type="fn" rid="fn1">
                        <sup>‡</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Conde</surname>
                        <given-names>Lucia</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff3">
                        <sup>3</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Hjalgrim</surname>
                        <given-names>Henrik</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff5">
                        <sup>5</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Kumar</surname>
                        <given-names>Vikrant</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff2">
                        <sup>2</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Chang</surname>
                        <given-names>Ellen T.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff6">
                        <sup>6</sup>
                    </xref>
                    <xref ref-type="aff" rid="aff7">
                        <sup>7</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Rothman</surname>
                        <given-names>Nathaniel</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff8">
                        <sup>8</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Cerhan</surname>
                        <given-names>James R.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff9">
                        <sup>9</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Brooks-Wilson</surname>
                        <given-names>Angela R.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff10">
                        <sup>10</sup>
                    </xref>
                    <xref ref-type="aff" rid="aff11">
                        <sup>11</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Rehnberg</surname>
                        <given-names>Emil</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff4">
                        <sup>4</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Irwan</surname>
                        <given-names>Ishak D.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff2">
                        <sup>2</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Ryder</surname>
                        <given-names>Lars P.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff12">
                        <sup>12</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Brown</surname>
                        <given-names>Peter N.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff13">
                        <sup>13</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Bracci</surname>
                        <given-names>Paige M.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff14">
                        <sup>14</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Agana</surname>
                        <given-names>Luz</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff3">
                        <sup>3</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Riby</surname>
                        <given-names>Jacques</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff3">
                        <sup>3</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Cozen</surname>
                        <given-names>Wendy</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff15">
                        <sup>15</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Davis</surname>
                        <given-names>Scott</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff16">
                        <sup>16</sup>
                    </xref>
                    <xref ref-type="aff" rid="aff17">
                        <sup>17</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Hartge</surname>
                        <given-names>Patricia</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff8">
                        <sup>8</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Morton</surname>
                        <given-names>Lindsay M.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff8">
                        <sup>8</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Severson</surname>
                        <given-names>Richard K.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff18">
                        <sup>18</sup>
                    </xref>
                    <xref ref-type="aff" rid="aff19">
                        <sup>19</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Wang</surname>
                        <given-names>Sophia S.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff8">
                        <sup>8</sup>
                    </xref>
                    <xref ref-type="aff" rid="aff20">
                        <sup>20</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Slager</surname>
                        <given-names>Susan L.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff9">
                        <sup>9</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Fredericksen</surname>
                        <given-names>Zachary S.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff9">
                        <sup>9</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Novak</surname>
                        <given-names>Anne J.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff9">
                        <sup>9</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Kay</surname>
                        <given-names>Neil E.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff9">
                        <sup>9</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Habermann</surname>
                        <given-names>Thomas M.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff9">
                        <sup>9</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Armstrong</surname>
                        <given-names>Bruce</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff21">
                        <sup>21</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Kricker</surname>
                        <given-names>Anne</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff21">
                        <sup>21</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Milliken</surname>
                        <given-names>Sam</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff22">
                        <sup>22</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Purdue</surname>
                        <given-names>Mark P.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff8">
                        <sup>8</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Vajdic</surname>
                        <given-names>Claire M.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff23">
                        <sup>23</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Boyle</surname>
                        <given-names>Peter</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff24">
                        <sup>24</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Lan</surname>
                        <given-names>Qing</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff8">
                        <sup>8</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Zahm</surname>
                        <given-names>Shelia H.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff8">
                        <sup>8</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Zhang</surname>
                        <given-names>Yawei</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff25">
                        <sup>25</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Zheng</surname>
                        <given-names>Tongzhang</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff25">
                        <sup>25</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Leach</surname>
                        <given-names>Stephen</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff26">
                        <sup>26</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Spinelli</surname>
                        <given-names>John J.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff10">
                        <sup>10</sup>
                    </xref>
                    <xref ref-type="aff" rid="aff27">
                        <sup>27</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Smith</surname>
                        <given-names>Martyn T.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff3">
                        <sup>3</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Chanock</surname>
                        <given-names>Stephen J.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff8">
                        <sup>8</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Padyukov</surname>
                        <given-names>Leonid</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff28">
                        <sup>28</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Alfredsson</surname>
                        <given-names>Lars</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff29">
                        <sup>29</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Klareskog</surname>
                        <given-names>Lars</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff28">
                        <sup>28</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Glimelius</surname>
                        <given-names>Bengt</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff30">
                        <sup>30</sup>
                    </xref>
                    <xref ref-type="aff" rid="aff31">
                        <sup>31</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Melbye</surname>
                        <given-names>Mads</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff5">
                        <sup>5</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Liu</surname>
                        <given-names>Edison T.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff2">
                        <sup>2</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Adami</surname>
                        <given-names>Hans-Olov</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff4">
                        <sup>4</sup>
                    </xref>
                    <xref ref-type="aff" rid="aff32">
                        <sup>32</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Humphreys</surname>
                        <given-names>Keith</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff4">
                        <sup>4</sup>
                    </xref>
                    <xref ref-type="fn" rid="fn2">
                        <sup>¶</sup>
                    </xref>
                </contrib>
                <contrib contrib-type="author" xlink:type="simple">
                    <name name-style="western">
                        <surname>Liu</surname>
                        <given-names>Jianjun</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff2">
                        <sup>2</sup>
                    </xref>
                    <xref ref-type="corresp" rid="cor1">
                        <sup>*</sup>
                    </xref>
                    <xref ref-type="fn" rid="fn2">
                        <sup>¶</sup>
                    </xref>
                </contrib>
            </contrib-group><aff id="aff1">
                <label>1</label>
                <addr-line>Department of Medicine, Clinical Epidemiology Unit, Karolinska
                    Institutet, Stockholm, Sweden</addr-line>
            </aff><aff id="aff2">
                <label>2</label>
                <addr-line>Human Genetics, Genome Institute of Singapore, A*STAR, Singapore,
                    Singapore</addr-line>
            </aff><aff id="aff3">
                <label>3</label>
                <addr-line>Division of Environmental Health Sciences, School of Public Health,
                    University of California Berkeley, Berkeley, California, United States of
                    America</addr-line>
            </aff><aff id="aff4">
                <label>4</label>
                <addr-line>Department of Medical Epidemiology and Biostatistics, Karolinska
                    Institutet, Stockholm, Sweden</addr-line>
            </aff><aff id="aff5">
                <label>5</label>
                <addr-line>Department of Epidemiology Research, Statens Serum Institut, Copenhagen,
                    Denmark</addr-line>
            </aff><aff id="aff6">
                <label>6</label>
                <addr-line>Cancer Prevention Institute of California, Fremont, California, United
                    States of America</addr-line>
            </aff><aff id="aff7">
                <label>7</label>
                <addr-line>Division of Epidemiology, Department of Health Research and Policy,
                    Stanford University School of Medicine, Stanford, California, United States of
                    America</addr-line>
            </aff><aff id="aff8">
                <label>8</label>
                <addr-line>Division of Cancer Epidemiology and Genetics, National Cancer Institute,
                    National Institutes of Health, Bethesda, Maryland, United States of
                    America</addr-line>
            </aff><aff id="aff9">
                <label>9</label>
                <addr-line>College of Medicine, Mayo Clinic, Rochester, Minnesota, United States of
                    America</addr-line>
            </aff><aff id="aff10">
                <label>10</label>
                <addr-line>British Columbia Cancer Research Center, British Columbia Cancer Agency,
                    Vancouver, Canada</addr-line>
            </aff><aff id="aff11">
                <label>11</label>
                <addr-line>Department of Biomedical Physiology and Kinesiology, Simon Fraser
                    University, Burnaby, Canada</addr-line>
            </aff><aff id="aff12">
                <label>12</label>
                <addr-line>Department of Clinical Immunology, University Hospital of Copenhagen,
                    Copenhagen, Denmark</addr-line>
            </aff><aff id="aff13">
                <label>13</label>
                <addr-line>Department of Haematology, Copenhagen University Hospital,
                    Copenhagen, Denmark</addr-line>
            </aff><aff id="aff14">
                <label>14</label>
                <addr-line>Department of Epidemiology and Biostatistics, University of California
                    San Francisco, San Francisco, California, United States of America</addr-line>
            </aff><aff id="aff15">
                <label>15</label>
                <addr-line>Department of Preventive Medicine, Keck School of Medicine, University of
                    Southern California, Los Angeles, California, United States of
                    America</addr-line>
            </aff><aff id="aff16">
                <label>16</label>
                <addr-line>Fred Hutchinson Cancer Research Center, Seattle, Washington, United
                    States of America</addr-line>
            </aff><aff id="aff17">
                <label>17</label>
                <addr-line>University of Washington, Seattle, Washington, United States of
                    America</addr-line>
            </aff><aff id="aff18">
                <label>18</label>
                <addr-line>Department of Family Medicine and Public Health Sciences, Wayne State
                    University, Detroit, Michigan, United States of America</addr-line>
            </aff><aff id="aff19">
                <label>19</label>
                <addr-line>Karmanos Cancer Institute, Detroit, Michigan, United States of
                    America</addr-line>
            </aff><aff id="aff20">
                <label>20</label>
                <addr-line>Division of Etiology, Beckman Research Institute and the City of Hope,
                    Duarte, California, United States of America</addr-line>
            </aff><aff id="aff21">
                <label>21</label>
                <addr-line>Sydney School of Public Health, The University of Sydney, Sydney,
                    Australia</addr-line>
            </aff><aff id="aff22">
                <label>22</label>
                <addr-line>Department of Haematology, St. Vincent's Hospital, Sydney,
                    Australia</addr-line>
            </aff><aff id="aff23">
                <label>23</label>
                <addr-line>University of New South Wales Cancer Research Center, Prince of Wales
                    Clinical School, Sydney, Australia</addr-line>
            </aff><aff id="aff24">
                <label>24</label>
                <addr-line>International Prevention Research Institute, Lyon, France</addr-line>
            </aff><aff id="aff25">
                <label>25</label>
                <addr-line>School of Public Health, Yale University, New Haven, Connecticut, United
                    States of America</addr-line>
            </aff><aff id="aff26">
                <label>26</label>
                <addr-line>Canada's Michael Smith Genome Sciences Centre, British Columbia
                    Cancer Agency, Vancouver, Canada</addr-line>
            </aff><aff id="aff27">
                <label>27</label>
                <addr-line>School of Population and Public Health, University of British Columbia,
                    Vancouver, Canada</addr-line>
            </aff><aff id="aff28">
                <label>28</label>
                <addr-line>Rheumatology Unit, Department of Medicine, Karolinska Institutet and
                    Karolinska University Hospital Solna, Stockholm, Sweden</addr-line>
            </aff><aff id="aff29">
                <label>29</label>
                <addr-line>Institute of Environmental Medicine, Karolinska Institutet, Stockholm,
                    Sweden</addr-line>
            </aff><aff id="aff30">
                <label>30</label>
                <addr-line>Department of Pathology and Oncology, Karolinska Institutet, Stockholm,
                    Sweden</addr-line>
            </aff><aff id="aff31">
                <label>31</label>
                <addr-line>Department of Radiology, Oncology, and Radiation Sciences, Uppsala
                    University, Uppsala, Sweden</addr-line>
            </aff><aff id="aff32">
                <label>32</label>
                <addr-line>Department of Epidemiology, Harvard School of Public Health, Boston,
                    Massachusetts, United States of America</addr-line>
            </aff><contrib-group>
                <contrib contrib-type="editor" xlink:type="simple">
                    <name name-style="western">
                        <surname>Gibson</surname>
                        <given-names>Greg</given-names>
                    </name>
                    <role>Editor</role>
                    <xref ref-type="aff" rid="edit1"/>
                </contrib>
            </contrib-group><aff id="edit1">Georgia Institute of Technology, United States of America</aff><author-notes>
                <corresp id="cor1">* E-mail: <email xlink:type="simple">liuj3@gis.a-star.edu.sg</email></corresp>
                <fn fn-type="con">
                    <p>Conceived and designed the experiments: KES ETL HOA JL. Performed the
                        experiments: IDI. Analyzed the data: KES JNF CFS HD LC VK ER KH JL.
                        Contributed reagents/materials/analysis tools: KES CFS LC HH ETC NR JRC LPR
                        PNB PMB LA JR WC SD PH LMM RKS SSW SLS ZSF AJN NEK TMH BA AK SM MPP CMV PB
                        QL SHZ YZ TZ SL JJS MTS SJC LP LA LK BG MM ETL HOA JL. Wrote the paper: KES
                        JNF KH JL. Critical revision of manuscript: CFS HD LC VK ETC IDI SJC.
                        Genotyped samples and provided data from the BC study: ARBW. Provided data
                        from the SF1 and SF2 GWAS studies: JR. Supervised the experiments: JL
                        JNF.</p>
                </fn>
                <fn fn-type="other" id="fn1">
                    <p>‡ These authors also contributed equally to this work.</p>
                </fn>
                <fn fn-type="other" id="fn2">
                    <p>¶ These authors also contributed equally to this work.</p>
                </fn>
            <fn fn-type="conflict">
                <p>The authors have declared that no competing interests exist.</p>
            </fn></author-notes><pub-date pub-type="collection">
                <month>4</month>
                <year>2011</year>
            </pub-date><pub-date pub-type="epub">
                <day>21</day>
                <month>4</month>
                <year>2011</year>
            </pub-date><volume>7</volume><issue>4</issue><elocation-id>e1001378</elocation-id><history>
                <date date-type="received">
                    <day>24</day>
                    <month>9</month>
                    <year>2010</year>
                </date>
                <date date-type="accepted">
                    <day>18</day>
                    <month>3</month>
                    <year>2011</year>
                </date>
            </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2011</copyright-year><license><license-p>This is an open-access article, free of all copyright, and may be
                freely reproduced, distributed, transmitted, modified, built upon, or otherwise used
                by anyone for any lawful purpose.  The work is made available under the Creative
                Commons CC0 public domain dedication.</license-p></license></permissions><abstract>
                <p>Non-Hodgkin lymphoma (NHL) represents a diverse group of hematological
                    malignancies, of which follicular lymphoma (FL) is a prevalent subtype. A
                    previous genome-wide association study has established a marker, rs10484561 in
                    the human leukocyte antigen (HLA) class II region on 6p21.32 associated with
                    increased FL risk. Here, in a three-stage genome-wide association study,
                    starting with a genome-wide scan of 379 FL cases and 791 controls followed by
                    validation in 1,049 cases and 5,790 controls, we identified a second independent
                    FL–associated locus on 6p21.32, rs2647012
                    (OR<sub>combined</sub> = 0.64,
                        P<sub>combined</sub> = 2×10<sup>−21</sup>)
                    located 962 bp away from rs10484561 (r<sup>2</sup>&lt;0.1 in controls). After
                    mutual adjustment, the associations at the two SNPs remained genome-wide
                    significant (rs2647012:OR<sub>adjusted</sub> = 0.70,
                        P<sub>adjusted</sub> = 4×10<sup>−12</sup>;
                        rs10484561:OR<sub>adjusted</sub> = 1.64,
                        P<sub>adjusted</sub> = 5×10<sup>−15</sup>).
                    Haplotype and coalescence analyses indicated that rs2647012 arose on an
                    evolutionarily distinct haplotype from that of rs10484561 and tags a novel
                    allele with an opposite (protective) effect on FL risk. Moreover, in a follow-up
                    analysis of the top 6 FL–associated SNPs in 4,449 cases of other NHL
                    subtypes, rs10484561 was associated with risk of diffuse large B-cell lymphoma
                        (OR<sub>combined</sub> = 1.36,
                        P<sub>combined</sub> = 1.4×10<sup>−7</sup>).
                    Our results reveal the presence of allelic heterogeneity within the HLA class II
                    region influencing FL susceptibility and indicate a possible shared genetic
                    etiology with diffuse large B-cell lymphoma. These findings suggest that the HLA
                    class II region plays a complex yet important role in NHL.</p>
            </abstract><abstract abstract-type="summary">
                <title>Author Summary</title>
                <p>Earlier studies have established a marker rs10484561, in the HLA class II region
                    on 6p21.32, associated with increased follicular lymphoma (FL) risk. Here, in a
                    three-stage genome-wide association study of 1,428 FL cases and 6,581 controls,
                    we identified a second independent FL–associated marker on 6p21.32,
                    rs2647012, located 962 bp away from rs10484561. The associations at two SNPs
                    remained genome-wide significant after mutual adjustment. Haplotype and
                    coalescence analyses indicated that rs2647012 arose on an evolutionarily
                    distinct lineage from that of rs10484561 and tags a novel allele with an
                    opposite, protective effect on FL risk. Moreover, in an analysis of the top 6
                    FL–associated SNPs in 4,449 cases of other NHL subtypes, rs10484561 was
                    associated with risk of diffuse large B-cell lymphoma. Our results reveal the
                    presence of allelic heterogeneity at 6p21.32 in FL risk and suggest a shared
                    genetic etiology with the common diffuse large B-cell lymphoma subtype.</p>
            </abstract><funding-group><funding-statement>This work was funded by the Agency for Science and Technology and Research of
                    Singapore (A*STAR), the Swedish Cancer Society (090659), the Swedish
                    Research Council (K2008-64X-20737-01-2, 523-2006-972), and the Danish Medical
                    Research Council (FSS 09-63424). The collection of blood samples in the founding
                    case-control study was supported by the National Cancer Institute (NCI)
                    (CA069269-01). Sample collection in EIRA was supported by the Swedish Council
                    for Working life (2008-0567), the AFA insurance company, and by the Combine
                    project founded by Vinnova. The SF1 and SF2 studies were supported by the NCI,
                    National Institutes of Health (NIH) (CA122663, CA104682, CA45614, CA89745). The
                    NCI-SEER study was supported by the Intramural Research Program of the NIH (NCI)
                    and by Public Health Service contracts N01-PC-65064, N01-PC-67008, N01-PC-67009,
                    N01-PC-67010, and N02-PC-71105. The Mayo study was supported by the NIH (NCI)
                    (R01- CA91253, R01-CA118444). The NSW study was supported by a National Health
                    and Medical Research Council of Australia project grant, Cancer Council NSW, a
                    University of Sydney Medical Foundation Program Grant, and the Intramural
                    Research Program of the US NIH (NCI). The Yale study was supported by grant
                    CA62006 from NIH (NCI) and the Intramural Research Program of the National
                    Institutes of Health (NCI). The BC study was funded from the Canadian Cancer
                    Society and the Canadian Institutes of Health Research. ARB-W is a Senior
                    Scholar of the Michael Smith Foundation for Health Research. The funders had no
                    role in study design, data collection and analysis, decision to publish, or
                    preparation of the manuscript.</funding-statement></funding-group><counts>
                <page-count count="11"/>
            </counts></article-meta>
    </front>
    <body>
        <sec id="s1">
            <title>Introduction</title>
            <p>Non-Hodgkin lymphoma (NHL) represents a diverse group of B- and T-cell malignancies
                of lymphatic origin. The most common subtypes are of B-cell origin and are further
                classified on the basis of their resemblance to normal stages of B-cell
                differentiation <xref ref-type="bibr" rid="pgen.1001378-Jaffe1">[1]</xref>. Epidemiological studies indicate that these may have
                different environmental and genetic risk factors, although some etiological factors
                may also be shared <xref ref-type="bibr" rid="pgen.1001378-Morton1">[2]</xref>. Familial studies provide substantial evidence for a
                genetic influence on susceptibility to the major mature B-cell neoplasms, including
                diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic
                lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) <xref ref-type="bibr" rid="pgen.1001378-Altieri1">[3]</xref>, <xref ref-type="bibr" rid="pgen.1001378-Chang1">[4]</xref>. Recent genome-wide association
                studies (GWAS) of the FL subtype of NHL identified associations with two variants
                within the human leukocyte antigen (HLA) region, one at 6p21.33 (rs6457327) <xref ref-type="bibr" rid="pgen.1001378-Skibola1">[5]</xref> and the other
                at 6p21.32 (rs10484561) <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>. Additional true associations, particularly in the HLA
                region, may have been missed because a limited number of samples were used in the
                initial genome-wide screens, and the selection of a few top single nucleotide
                polymorphisms (SNPs) for validation is further subject to chance. In this study, we
                conducted a larger independent genome-wide scan of FL using 379 cases and 791
                controls from the Scandinavian Lymphoma Etiology (SCALE) study of Sweden and
                Denmark, which was used in the validation of the previous GWAS <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>. This scan was followed by two
                stages of validation in European-ancestry cases of FL and other common B-cell NHL
                subtypes and controls from the US, Canada and Australia (<xref ref-type="table" rid="pgen-1001378-t001">Table 1</xref>, <xref ref-type="supplementary-material" rid="pgen.1001378.s007">Table S1</xref>, <xref ref-type="supplementary-material" rid="pgen.1001378.s008">Table S2</xref>, <xref ref-type="fig" rid="pgen-1001378-g001">Figure 1</xref>).</p>
            <fig id="pgen-1001378-g001" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pgen.1001378.g001</object-id>
                <label>Figure 1</label>
                <caption>
                    <title>Schematic representation of the three-stage study design.</title>
                    <p>Summary of contributing studies and number of samples per case/control
                        status. Abbreviations: FL: follicular lymphoma, NHL: non-Hodgkin lymphoma,
                        DLBCL: diffuse large B-cell lymphoma, CLL/SLL: chronic lymphocytic
                        leukemia/small lymphocytic lymphoma, SNP: single nucleotide polymorphism,
                        GWAS: genome-wide association study, SCALE: Scandinavian lymphoma etiology,
                        SF: San Francisco, BC: British Columbia, NCI-SEER: National Cancer
                        Institute-Surveillance, Epidemiology and End Results, NSW: New South Wales,
                        Yale: Yale University, Mayo: Mayo Clinic. The complete list of the number of
                        other NHL subtypes in each study is detailed in <xref ref-type="supplementary-material" rid="pgen.1001378.s007">Table
                            S1</xref>.</p>
                </caption>
                <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.g001" xlink:type="simple"/>
            </fig>
            <table-wrap id="pgen-1001378-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1001378.t001</object-id><label>Table 1</label><caption>
                    <title>Summary of contributing studies, genotyping methods, and number of
                        samples per case/control status.</title>
                </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pgen-1001378-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.t001" xlink:type="simple"/><table>
                    <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                    </colgroup>
                    <thead>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">Stage</td>
                            <td align="left" colspan="1" rowspan="1">Study</td>
                            <td align="left" colspan="1" rowspan="1">Population</td>
                            <td align="left" colspan="1" rowspan="1">Genotyping method</td>
                            <td align="left" colspan="1" rowspan="1">Controls</td>
                            <td align="left" colspan="1" rowspan="1">FL</td>
                            <td align="left" colspan="1" rowspan="1">Other NHL subtypes<xref ref-type="table-fn" rid="nt102">*</xref></td>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">1</td>
                            <td align="left" colspan="1" rowspan="1">SCALE1</td>
                            <td align="left" colspan="1" rowspan="1">Denmark/Sweden</td>
                            <td align="left" colspan="1" rowspan="1">Illumina 317k</td>
                            <td align="left" colspan="1" rowspan="1">791</td>
                            <td align="left" colspan="1" rowspan="1">379</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">2</td>
                            <td align="left" colspan="1" rowspan="1">SF1</td>
                            <td align="left" colspan="1" rowspan="1">San Francisco Bay Area, USA</td>
                            <td align="left" colspan="1" rowspan="1">Illumina HumanCNV370-Duo Beadchip</td>
                            <td align="left" colspan="1" rowspan="1">750</td>
                            <td align="left" colspan="1" rowspan="1">213</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">3/subtype validation</td>
                            <td align="left" colspan="1" rowspan="1">NCI-SEER</td>
                            <td align="left" colspan="1" rowspan="1">USA</td>
                            <td align="left" colspan="1" rowspan="1">Taqman</td>
                            <td align="left" colspan="1" rowspan="1">501</td>
                            <td align="left" colspan="1" rowspan="1">157</td>
                            <td align="left" colspan="1" rowspan="1">468</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">NSW</td>
                            <td align="left" colspan="1" rowspan="1">New South Wales, Australia</td>
                            <td align="left" colspan="1" rowspan="1">Taqman</td>
                            <td align="left" colspan="1" rowspan="1">398</td>
                            <td align="left" colspan="1" rowspan="1">161</td>
                            <td align="left" colspan="1" rowspan="1">261</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">Yale</td>
                            <td align="left" colspan="1" rowspan="1">USA</td>
                            <td align="left" colspan="1" rowspan="1">Taqman</td>
                            <td align="left" colspan="1" rowspan="1">460</td>
                            <td align="left" colspan="1" rowspan="1">98</td>
                            <td align="left" colspan="1" rowspan="1">300</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">BC</td>
                            <td align="left" colspan="1" rowspan="1">British Columbia, Canada</td>
                            <td align="left" colspan="1" rowspan="1">Taqman</td>
                            <td align="left" colspan="1" rowspan="1">610</td>
                            <td align="left" colspan="1" rowspan="1">174</td>
                            <td align="left" colspan="1" rowspan="1">451</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">Mayo</td>
                            <td align="left" colspan="1" rowspan="1">Minnesota, Iowa, Wisconsin, USA</td>
                            <td align="left" colspan="1" rowspan="1">OPA</td>
                            <td align="left" colspan="1" rowspan="1">1233</td>
                            <td align="left" colspan="1" rowspan="1">246</td>
                            <td align="left" colspan="1" rowspan="1">843</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">SCALE2</td>
                            <td align="left" colspan="1" rowspan="1">Denmark/Sweden</td>
                            <td align="left" colspan="1" rowspan="1">Sequenom/Taqman</td>
                            <td align="left" colspan="1" rowspan="1">2018</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">1869</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">SF2</td>
                            <td align="left" colspan="1" rowspan="1">San Francisco Bay Area, USA</td>
                            <td align="left" colspan="1" rowspan="1">Illumina HumanCNV370-Duo Beadchip</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">257</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>Total</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>6761</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>1428</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>4449</bold>
                            </td>
                        </tr>
                    </tbody>
                </table></alternatives><table-wrap-foot>
                    <fn id="nt101">
                        <label/>
                        <p>Abbreviations: SCALE: Scandinavian lymphoma etiology, SF: San Francisco,
                            NCI-SEER: National Cancer Institute- Surveillance, Epidemiology and End
                            Results, NSW: New South Wales, Yale: Yale University, BC: British
                            Columbia, Mayo: Mayo Clinic, OPA: oligonucleotuide pool assays (Illumina
                            GoldenGate).</p>
                    </fn>
                    <fn id="nt102">
                        <label/>
                        <p>*The complete list of the number of other NHL subtypes in each study
                            is detailed in <xref ref-type="supplementary-material" rid="pgen.1001378.s007">Table S1</xref>.</p>
                    </fn>
                </table-wrap-foot></table-wrap>
        </sec>
        <sec id="s2">
            <title>Results</title>
            <p>In total, 298,168 SNPs were analyzed in Stage 1 (λ = 1.028;
                    λ<sub>1000</sub> = 1.055 <xref ref-type="bibr" rid="pgen.1001378-deBakker1">[7]</xref>), in which we observed
                suggestive associations (adjusted trend P-value&lt;10<sup>−5</sup>) at 4q32.3,
                6p21.32 and 10q25.3 (<xref ref-type="supplementary-material" rid="pgen.1001378.s009">Table S3</xref>) with the strongest at rs2647012 (odds ratio
                (OR) = 0.58, P<sub>PCAadjusted</sub> = 
                    1.59x10<sup>−7</sup>) within the HLA class II region on 6p21.32. Sixteen
                SNPs in close proximity to the <italic>HLA-DQ</italic> genes showed association with
                adjusted P-values&lt;10<sup>−4</sup>, including the previously reported
                rs10484561 (<xref ref-type="fig" rid="pgen-1001378-g002">Figure 2</xref>, <xref ref-type="supplementary-material" rid="pgen.1001378.s010">Table S4</xref>) <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>. The previously
                reported HLA class I associated SNP rs6457327 <xref ref-type="bibr" rid="pgen.1001378-Skibola1">[5]</xref> was modestly associated with FL
                risk (OR = 0.82, P = 0.03) in Stage 1, and
                was not in linkage disequilibrium (LD; r<sup>2</sup> = 0) with
                any of the top 100 SNPs.</p>
            <p>In Stage 2, we carried out an <italic>in silico</italic> validation of the top 40
                SNPs from Stage 1 (<xref ref-type="supplementary-material" rid="pgen.1001378.s011">Table S5</xref>) in 213 FL cases and 750 controls from the San Francisco Bay
                Area, USA (<xref ref-type="table" rid="pgen-1001378-t001">Table 1</xref>), the study
                that reported an association at 6p21.32 <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>. Among 38 out of 40 SNPs, seven
                showed association (P&lt;0.05) in Stage 2 (<xref ref-type="supplementary-material" rid="pgen.1001378.s011">Table S5</xref>), six of which were located within the
                6p21.32 region. We tested the independence of multiple association signals in
                6p21.32 using a stepwise logistic regression analysis (entering SNPs based on a
                criterion of likelihood ratio test p-value&lt;0.05) and found that with rs2647012
                (the top SNP within the region) forced in the model, only the addition of rs10484561
                contributed significantly to the association with increased risk of FL. The OR for
                this SNP, adjusted for rs2647012, was 1.43, P = 0.006 (<xref ref-type="supplementary-material" rid="pgen.1001378.s012">Table S6</xref>).</p>
            <fig id="pgen-1001378-g002" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pgen.1001378.g002</object-id>
                <label>Figure 2</label>
                <caption>
                    <title>Recombination plot showing associations in 6p21.32 in Stage 1.</title>
                    <p>Plot showing the pattern of associations in Stage 1, the recombination rate
                        (build 36, HapMap CEU) and genes located in the region. The two SNPs showing
                        independent association and their respective P-values are labeled (blue:
                        rs2647012, green: rs10484561); other SNPs are color-coded according to their
                        LD with rs2647012 (red r<sup>2</sup>&gt;0.8, orange 0.5–0.8, grey
                        0.2–0.5, white &lt;0.2).</p>
                </caption>
                <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.g002" xlink:type="simple"/>
            </fig>
            <p>After excluding previously identified and non-independent association signals, we
                selected rs2647012, and an additional four top SNPs to be taken forward to a third
                stage (<xref ref-type="supplementary-material" rid="pgen.1001378.s013">Table
                    S7</xref>, <xref ref-type="supplementary-material" rid="pgen.1001378.s014">S8</xref>), wherein these were genotyped in 836 FL cases and 3202 controls from
                the Mayo Clinic (US) <xref ref-type="bibr" rid="pgen.1001378-Cerhan1">[8]</xref>, National Cancer Institute-Surveillance, Epidemiology and
                End Results (NCI-SEER, US) <xref ref-type="bibr" rid="pgen.1001378-Wang1">[9]</xref>, Yale University (US) <xref ref-type="bibr" rid="pgen.1001378-Zhang1">[10]</xref>, New South Wales (NSW,
                Australia) <xref ref-type="bibr" rid="pgen.1001378-Hughes1">[11]</xref>
                and British Columbia (BC, Canada) <xref ref-type="bibr" rid="pgen.1001378-Spinelli1">[12]</xref> studies. The association of rs2647012 with FL was
                validated, showing consistent associations with similar ORs (no heterogeneity,
                P = 0.32) across all independent studies and reaching
                genome-wide significance in both the combined analysis of the validation samples
                    (P = 3×10<sup>−15</sup>) and the combined
                analysis of all three stages (1428 FL cases, 4743 controls;
                OR = 0.64,
                    P = 2×10<sup>−21</sup>) (<xref ref-type="table" rid="pgen-1001378-t002">Table.2</xref>, <xref ref-type="fig" rid="pgen-1001378-g003">Figure 3</xref>). After adjustment for rs10484561, the
                association at rs2647012 remained genome-wide significant with minimal change in
                magnitude (OR<sub>adjusted</sub> = 0.70,
                    P<sub>adjusted</sub> = 4×10<sup>−12</sup>). The
                LD between the two SNPs is low (r<sup>2</sup>&lt;0.1 in the SCALE controls and
                HapMap CEU [Utah residents with northern and western European ancestry]
                samples release27). Taken together, our results suggest that the association at
                rs2647012 is independent from rs10484561, and tags a different disease-predisposing
                variant. We also found suggestive evidence for an association at rs6536942 on 4q32.3
                (OR = 1.36,
                    P = 2×10<sup>−5</sup>) (<xref ref-type="table" rid="pgen-1001378-t002">Table 2</xref>, <xref ref-type="supplementary-material" rid="pgen.1001378.s001">Figure S1A</xref>).</p>
            <fig id="pgen-1001378-g003" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pgen.1001378.g003</object-id>
                <label>Figure 3</label>
                <caption>
                    <title>Forest plots of main associations with risk of FL.</title>
                    <p>Forest plots showing the associations in each study (ORs and P-values) at
                        rs2647012 before adjustment
                        (P<sub>heterogeneity</sub> = 0.32), and at rs2647012
                            (P<sub>heterogeneity</sub> = 0.67) and rs10484561
                            (P<sub>heterogeneity</sub> = 0.54) after mutual
                        adjustment. Squares indicate the odds ratios, with the size proportional to
                        the weight of the study in the meta-analysis. Abbreviations: CI: confidence
                        interval, SCALE: Scandinavian lymphoma etiology, SF: San Francisco, BC:
                        British Columbia, NCI: National Cancer Institute-Surveillance, Epidemiology
                        and End Results, NSW: New South Wales, YALE: Yale University, MAYO: Mayo
                        Clinic.</p>
                </caption>
                <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.g003" xlink:type="simple"/>
            </fig>
            <table-wrap id="pgen-1001378-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1001378.t002</object-id><label>Table 2</label><caption>
                    <title>Summary of main findings in genome-wide association study (GWAS) and
                        validation stages in risk<xref ref-type="table-fn" rid="nt103">*</xref>
                        of follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), or
                        marginal zone lymphoma (MZL), per study and combined.</title>
                </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pgen-1001378-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.t002" xlink:type="simple"/><table>
                    <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                    </colgroup>
                    <thead>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="4" rowspan="1">FL</td>
                            <td align="left" colspan="1" rowspan="1">DLBCL</td>
                            <td align="left" colspan="1" rowspan="1">MZL</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">rs2647012</td>
                            <td align="left" colspan="1" rowspan="1">rs2647012adj for rs10484561<xref ref-type="table-fn" rid="nt104">**</xref></td>
                            <td align="left" colspan="1" rowspan="1">rs10484561adj for rs2647012<xref ref-type="table-fn" rid="nt104">**</xref></td>
                            <td align="left" colspan="1" rowspan="1">rs6536942</td>
                            <td align="left" colspan="1" rowspan="1">rs10484561</td>
                            <td align="left" colspan="1" rowspan="1">rs2647012</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">chr6:32772436 <italic>HLA-DQB1</italic></td>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">chr4:167205644 <italic>TLL1</italic></td>
                            <td align="left" colspan="1" rowspan="1">chr6:32773398 <italic>HLA-DQB1</italic></td>
                            <td align="left" colspan="1" rowspan="1">chr6:32772436 <italic>HLA-DQB1</italic></td>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>Stage 1</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">SCALE1</td>
                            <td align="left" colspan="1" rowspan="1">1×10<sup>−7</sup></td>
                            <td align="left" colspan="1" rowspan="1">1×10<sup>−5</sup></td>
                            <td align="left" colspan="1" rowspan="1">0.006</td>
                            <td align="left" colspan="1" rowspan="1">1×10<sup>−6</sup></td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">0.60 (0.50–0.73)</td>
                            <td align="left" colspan="1" rowspan="1">0.65 (0.53–0.79)</td>
                            <td align="left" colspan="1" rowspan="1">1.43 (1.11–1.84)</td>
                            <td align="left" colspan="1" rowspan="1">1.86 (1.45–2.34)</td>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>Stage 2</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">SF</td>
                            <td align="left" colspan="1" rowspan="1">0.005</td>
                            <td align="left" colspan="1" rowspan="1">0.08</td>
                            <td align="left" colspan="1" rowspan="1">0.002</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">0.04</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">0.72 (0.57–0.91)</td>
                            <td align="left" colspan="1" rowspan="1">0.80 (0.62–1.03)</td>
                            <td align="left" colspan="1" rowspan="1">1.60 (1.19–2.16)</td>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">1.36 (1.05–1.80)</td>
                            <td align="left" colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>Stage 3</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">BC</td>
                            <td align="left" colspan="1" rowspan="1">0.004</td>
                            <td align="left" colspan="1" rowspan="1">0.06</td>
                            <td align="left" colspan="1" rowspan="1">3×10<sup>−5</sup></td>
                            <td align="left" colspan="1" rowspan="1">0.72</td>
                            <td align="left" colspan="1" rowspan="1">0.001</td>
                            <td align="left" colspan="1" rowspan="1">0.01</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">0.69 (0.53–0.89)</td>
                            <td align="left" colspan="1" rowspan="1">0.77 (0.58–1.01)</td>
                            <td align="left" colspan="1" rowspan="1">2.06 (1.46–2.90)</td>
                            <td align="left" colspan="1" rowspan="1">1.08 (0.72–1.61)</td>
                            <td align="left" colspan="1" rowspan="1">1.77 (1.26–2.48)</td>
                            <td align="left" colspan="1" rowspan="1">1.56 (1.10–2.22)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">NCI-SEER</td>
                            <td align="left" colspan="1" rowspan="1">0.12</td>
                            <td align="left" colspan="1" rowspan="1">0.17</td>
                            <td align="left" colspan="1" rowspan="1">0.08</td>
                            <td align="left" colspan="1" rowspan="1">0.13</td>
                            <td align="left" colspan="1" rowspan="1">0.15</td>
                            <td align="left" colspan="1" rowspan="1">0.06</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">0.81 (0.61–1.06)</td>
                            <td align="left" colspan="1" rowspan="1">0.81 (0.59–1.10)</td>
                            <td align="left" colspan="1" rowspan="1">1.41 (0.96–2.08)</td>
                            <td align="left" colspan="1" rowspan="1">1.34 (0.92–1.95)</td>
                            <td align="left" colspan="1" rowspan="1">1.32 (0.90–1.94)</td>
                            <td align="left" colspan="1" rowspan="1">1.51 (0.99–2.31)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">NSW</td>
                            <td align="left" colspan="1" rowspan="1">1×10<sup>−4</sup></td>
                            <td align="left" colspan="1" rowspan="1">0.05</td>
                            <td align="left" colspan="1" rowspan="1">0.006</td>
                            <td align="left" colspan="1" rowspan="1">0.42</td>
                            <td align="left" colspan="1" rowspan="1">0.01</td>
                            <td align="left" colspan="1" rowspan="1">0.45</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">0.53 (0.38–0.73)</td>
                            <td align="left" colspan="1" rowspan="1">0.69 (0.48–1.01)</td>
                            <td align="left" colspan="1" rowspan="1">1.94 (1.21–3.11)</td>
                            <td align="left" colspan="1" rowspan="1">1.21 (0.76–1.91)</td>
                            <td align="left" colspan="1" rowspan="1">1.74 (1.12–2.72)</td>
                            <td align="left" colspan="1" rowspan="1">1.23 (0.72–2.08)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">Yale</td>
                            <td align="left" colspan="1" rowspan="1">0.008</td>
                            <td align="left" colspan="1" rowspan="1">0.04</td>
                            <td align="left" colspan="1" rowspan="1">0.14</td>
                            <td align="left" colspan="1" rowspan="1">0.74</td>
                            <td align="left" colspan="1" rowspan="1">0.40</td>
                            <td align="left" colspan="1" rowspan="1">0.73</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">0.63 (0.45–0.89)</td>
                            <td align="left" colspan="1" rowspan="1">0.69 (0.48–0.99)</td>
                            <td align="left" colspan="1" rowspan="1">1.38 (0.90–2.12)</td>
                            <td align="left" colspan="1" rowspan="1">1.08 (0.67–1.74)</td>
                            <td align="left" colspan="1" rowspan="1">1.18 (0.79–1.77)</td>
                            <td align="left" colspan="1" rowspan="1">1.10 (0.63–1.92)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">Mayo</td>
                            <td align="left" colspan="1" rowspan="1">1×10<sup>−7</sup></td>
                            <td align="left" colspan="1" rowspan="1">1×10<sup>−4</sup></td>
                            <td align="left" colspan="1" rowspan="1">0.28</td>
                            <td align="left" colspan="1" rowspan="1">0.28</td>
                            <td align="left" colspan="1" rowspan="1">0.01</td>
                            <td align="left" colspan="1" rowspan="1">0.38</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">0.56 (0.45–0.69)</td>
                            <td align="left" colspan="1" rowspan="1">0.64 (0.51–0.80)</td>
                            <td align="left" colspan="1" rowspan="1">1.17 (1.45–2.53)</td>
                            <td align="left" colspan="1" rowspan="1">1.17 (0.88–1.56)</td>
                            <td align="left" colspan="1" rowspan="1">1.52 (1.11–2.08)</td>
                            <td align="left" colspan="1" rowspan="1">1.18 (0.82–1.69)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">SCALE2</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">0.08</td>
                            <td align="left" colspan="1" rowspan="1">0.10</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">1.19 (0.98–1.44)</td>
                            <td align="left" colspan="1" rowspan="1">1.29 (0.95–1.74)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">Joint</td>
                            <td align="left" colspan="1" rowspan="1">3×10<sup>−15</sup></td>
                            <td align="left" colspan="1" rowspan="1">6×10<sup>−8</sup></td>
                            <td align="left" colspan="1" rowspan="1">9×10<sup>−14</sup></td>
                            <td align="left" colspan="1" rowspan="1">0.06</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                            <td align="left" colspan="1" rowspan="1">-</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">0.65 (0.58–0.72)</td>
                            <td align="left" colspan="1" rowspan="1">0.73 (0.65–0.82)</td>
                            <td align="left" colspan="1" rowspan="1">1.72 (1.49–1.98)</td>
                            <td align="left" colspan="1" rowspan="1">1.18 (1.00–1.40)</td>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"><bold>All</bold> (Stages 1,2,3)</td>
                            <td align="left" colspan="1" rowspan="1">2×10<sup>−21</sup></td>
                            <td align="left" colspan="1" rowspan="1">4×10<sup>−12</sup></td>
                            <td align="left" colspan="1" rowspan="1">5×10<sup>−15</sup></td>
                            <td align="left" colspan="1" rowspan="1">2×10<sup>−5</sup></td>
                            <td align="left" colspan="1" rowspan="1">1×10<sup>−7</sup></td>
                            <td align="left" colspan="1" rowspan="1">6×10<sup>−4</sup></td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">0.64 (0.58–0.70)</td>
                            <td align="left" colspan="1" rowspan="1">0.70 (0.67–0.78)</td>
                            <td align="left" colspan="1" rowspan="1">1.64 (1.45–1.86)</td>
                            <td align="left" colspan="1" rowspan="1">1.36 (1.18–1.56)</td>
                            <td align="left" colspan="1" rowspan="1">1.36 (1.21–1.52)</td>
                            <td align="left" colspan="1" rowspan="1">1.32 (1.13–1.55)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">P<sub>heterogeneity</sub><xref ref-type="table-fn" rid="nt105">†</xref></td>
                            <td align="left" colspan="1" rowspan="1">0.32</td>
                            <td align="left" colspan="1" rowspan="1">0.67</td>
                            <td align="left" colspan="1" rowspan="1">0.54</td>
                            <td align="left" colspan="1" rowspan="1">0.09</td>
                            <td align="left" colspan="1" rowspan="1">0.28</td>
                            <td align="left" colspan="1" rowspan="1">0.83</td>
                        </tr>
                    </tbody>
                </table></alternatives><table-wrap-foot>
                    <fn id="nt103">
                        <label/>
                        <p>*The trend test P-value for each study is shown with the
                            corresponding odds ratios (OR) and confidence interval (CI) below.</p>
                    </fn>
                    <fn id="nt104">
                        <label/>
                        <p>**Additional adjustment for rs6457327, rs4947332, rs1794265,
                            rs1800629, rs2517448 did not confer other than marginal changes.</p>
                    </fn>
                    <fn id="nt105">
                        <label/>
                        <p>†Test of heterogeneity carried out assuming heterogeneity of
                            effect of the “other” SNP.</p>
                    </fn>
                    <fn id="nt106">
                        <label/>
                        <p>SCALE: Scandinavian Lymphoma Etiology; SF: San Francisco; BC: British
                            Columbia; NCI-SEER: National Cancer Institute-Surveillance, Epidemiology
                            and End Results; NSW: New South Wales.</p>
                    </fn>
                </table-wrap-foot></table-wrap>
            <p>To fine-map the association signals in the HLA class II region, we imputed 10,639
                SNPs within 600 kb surrounding the top SNP rs2647012 using data from the 1000
                Genomes (1000G, 60 CEU subjects, August 2009) and HapMap projects (HapMapII release
                22, CEU) in Stage 1. Among the imputed SNPs, 258 SNPs located in a strong LD block
                of 236 kb (r<sup>2</sup>&gt;0.8) showed stronger evidence of association than all
                the genotyped SNPs within the region (<xref ref-type="supplementary-material" rid="pgen.1001378.s002">Figure S2</xref>). Since a moderate discordance of
                reference genotypes was observed between 1000 G and HapMapII, we analyzed only SNPs
                showing a concordance of &gt;95% in the two datasets and identified the
                strongest association at rs9378212 (OR = 1.66,
                    P = 3.21×10<sup>−8</sup>), located 219 kb
                upstream of rs2647012 (r<sup>2</sup> = 0.56 in controls). We
                subsequently confirmed the imputed genotypes by Taqman genotyping in 345 of the FL
                case subjects used in Stage 1 and found a 99.4% concordance with the imputed
                genotypes, demonstrating high confidence in the results of the imputation.</p>
            <p>Next, we performed a haplotype analysis using rs2647012, rs10484561 and an additional
                12 adjacent genotyped SNPs located within a block of minimal recombination. Out of
                the eight haplotypes identified, three were neutral
                (OR = 0.9–1.1), three increased risk (ORs&gt;1.2;
                strongest risk haplotype tagged by rs10484561) and two were protective (OR≤0.8;
                both tagged by rs2647012) (<xref ref-type="supplementary-material" rid="pgen.1001378.s015">Table S9</xref>), suggesting the presence of at least
                two susceptibility alleles within the region. Coalescence analysis of the eight
                haplotypes indicated that rs2647012 and rs10484561 arose on two distal branches of
                the ancestral recombination graph <xref ref-type="bibr" rid="pgen.1001378-Song1">[13]</xref> (<xref ref-type="supplementary-material" rid="pgen.1001378.s003">Figure S3</xref>), which was also supported by the
                analysis of median-joining network <xref ref-type="bibr" rid="pgen.1001378-Bandelt1">[14]</xref> using seven SNPs without any recombination (<xref ref-type="fig" rid="pgen-1001378-g004">Figure 4</xref>). Further haplotype
                analysis of the seven genotyped SNPs (<xref ref-type="supplementary-material" rid="pgen.1001378.s015">Table S9</xref>) and the imputed SNP rs9378212 indicated
                that the two alleles of rs9378212 tag the two different evolutionary lineages (<xref ref-type="fig" rid="pgen-1001378-g004">Figure 4</xref>), each harboring either
                rs2647012 or rs10484561. Thus, the associations at the two SNPs are likely due to
                two distinct susceptibility variants, instead of a single risk allele, that arose
                independently on different haplotype backgrounds.</p>
            <fig id="pgen-1001378-g004" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pgen.1001378.g004</object-id>
                <label>Figure 4</label>
                <caption>
                    <title>Coalescence analysis of rs2647012 and rs10484561.</title>
                    <p>Median-joining network <xref ref-type="bibr" rid="pgen.1001378-Bandelt1">[14]</xref> of haplotypes constructed using seven SNPs (<xref ref-type="supplementary-material" rid="pgen.1001378.s015">Table
                            S9</xref>). Circles represent haplotypes with area proportional to their
                        frequency. SNPs are shown on the links (black lines). SNPs and haplotypes
                        associated with increased or decreased FL risk are labeled in red or blue,
                        respectively. The percentage of alleles of the imputed SNP rs9378212 (C/T)
                        phased on each haplotype are shown in bold.</p>
                </caption>
                <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.g004" xlink:type="simple"/>
            </fig>
            <p>The FL-associated SNP, rs10484561, was previously found to tag the extended haplotype
                    <italic>HLA-DQA1*0101-HLA-DQB1*0501-HLA-DRB1*0101</italic>
                <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>. Here, to test
                whether any HLA class II alleles may also be responsible for the observed
                association at rs2647012, we imputed known HLA tag SNPs <xref ref-type="bibr" rid="pgen.1001378-deBakker2">[15]</xref>, <xref ref-type="bibr" rid="pgen.1001378-Leslie1">[16]</xref> using data from the 1000G and
                HapMapII European datasets. We confirmed the association of the
                    <italic>HLA-DRB1*0101-HLA-DQA1*0101-HLA-DQB1*0501</italic> extended
                haplotype, tagged by rs10484561. The association at rs2647012 remained significant
                after adjustment for these three HLA alleles (OR = 0.64,
                    P = 8.11×10<sup>−6</sup>), suggesting that
                these are not driving the association at rs2647012. Furthermore, rs2647012 was not
                in strong LD (r<sup>2</sup>&lt;0.8 in HapMap CEU or SCALE controls) with any other
                known HLA tags <xref ref-type="bibr" rid="pgen.1001378-deBakker2">[15]</xref>, including those tagging FL-associated alleles previously
                reported <xref ref-type="bibr" rid="pgen.1001378-Wang2">[17]</xref>, <xref ref-type="bibr" rid="pgen.1001378-Abdou1">[18]</xref>
                (r<sup>2</sup>&lt;0.39 with the six <italic>HLA-DRB1*13</italic> tag SNPs
                [rs2395173, rs2157051, rs4434496, rs6901541, rs424232, rs2050191] <xref ref-type="bibr" rid="pgen.1001378-Wang2">[17]</xref> and
                r<sup>2</sup>&lt;0.25 with the three <italic>HLA-B*0801</italic> and
                    <italic>HLA-DRB*0301</italic> tag SNPs [rs6457374, rs2844535,
                rs2040410] <xref ref-type="bibr" rid="pgen.1001378-deBakker2">[15]</xref>). Of the other 17 HLA class II alleles (∼39%
                of all the class II alleles) that could be imputed, none showed significant
                association or were found to be responsible for the association at rs2647012 (<xref ref-type="supplementary-material" rid="pgen.1001378.s016">Table S10</xref>).
                Detailed HLA allelotyping on large numbers of cases and controls is needed to
                determine if particular HLA class II alleles are responsible for the observed
                association at rs2647012.</p>
            <p>To assess whether the FL-associated SNPs may be involved in the development of other
                NHL subtypes, we genotyped the five SNPs selected for Stage 3 together with
                rs10484561 in a total of 1592 DLBCL, 1075 CLL/SLL, 336 marginal zone lymphoma (MZL),
                262 mantle cell lymphoma, 306 T-cell lymphoma and 878 rare or unspecified NHL cases
                and 5220 controls from the SCALE2, SF2, BC, Mayo, NCI-SEER, Yale and NSW studies
                    (<xref ref-type="table" rid="pgen-1001378-t001">Table 1</xref>, <xref ref-type="supplementary-material" rid="pgen.1001378.s007">Table S1</xref>, <xref ref-type="fig" rid="pgen-1001378-g001">Figure 1</xref>). Among these SNPs,
                rs10484561 showed evidence of association with DLBCL
                (OR = 1.36,
                    P = 1.41×10<sup>−7</sup>) (<xref ref-type="supplementary-material" rid="pgen.1001378.s001">Figure S1B</xref>) and
                all NHL (OR = 1.23,
                    P = 6.81×10<sup>−7</sup>). ORs were consistent
                across the seven studies. There was also a suggestive association for rs2647012 with
                MZL (OR = 1.32,
                    P = 6.34×10<sup>−4</sup>) (<xref ref-type="table" rid="pgen-1001378-t003">Table.3</xref>), consistent across six
                studies.</p>
            <p>Finally, we investigated the possibility of additional susceptibility loci for FL
                outside of the HLA region by performing a joint analysis of the top 41 to 1000
                variants of our scan and the previously published GWAS of follicular lymphoma <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>. From this
                combined analysis, we did not find any additional markers with a strong association
                    (P&lt;10<sup>−6</sup>) with FL that were not in LD with our top 5 markers
                taken forward to stage 3 (data not shown).</p>
            <table-wrap id="pgen-1001378-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1001378.t003</object-id><label>Table 3</label><caption>
                    <title>Meta-analysis of associations between rs1048456, the top 5 markers, and
                        non-Hodgkin lymphoma (NHL) subtypes (including follicular lymphoma
                        [FL], diffuse large B-cell lymphoma [DLBCL], chronic
                        lymphocytic leukemia/small lymphocytic lymphoma [CLL/SLL], and
                        others) and overall (All NHL).</title>
                </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pgen-1001378-t003-3" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.t003" xlink:type="simple"/><table>
                    <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                    </colgroup>
                    <thead>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">FL<xref ref-type="table-fn" rid="nt107">*</xref></td>
                            <td align="left" colspan="1" rowspan="1">DLBCL</td>
                            <td align="left" colspan="1" rowspan="1">CLL/SLL</td>
                            <td align="left" colspan="1" rowspan="1">Marginal zone</td>
                            <td align="left" colspan="1" rowspan="1">Mantle cell</td>
                            <td align="left" colspan="1" rowspan="1">T-cell</td>
                            <td align="left" colspan="1" rowspan="1">All NHL<xref ref-type="table-fn" rid="nt107">*</xref></td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">Marker</td>
                            <td align="left" colspan="1" rowspan="1"><italic>P</italic>-value</td>
                            <td align="left" colspan="1" rowspan="1"><italic>P</italic>-value</td>
                            <td align="left" colspan="1" rowspan="1"><italic>P</italic>-value</td>
                            <td align="left" colspan="1" rowspan="1"><italic>P</italic>-value</td>
                            <td align="left" colspan="1" rowspan="1"><italic>P</italic>-value</td>
                            <td align="left" colspan="1" rowspan="1"><italic>P</italic>-value</td>
                            <td align="left" colspan="1" rowspan="1"><italic>P</italic>-value</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1"/>
                            <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                            <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                            <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                            <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                            <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                            <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                            <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>rs10484561</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1">1.06×10<sup>−21</sup></td>
                            <td align="left" colspan="1" rowspan="1">1.41×10<sup>−7</sup></td>
                            <td align="left" colspan="1" rowspan="1">0.05</td>
                            <td align="left" colspan="1" rowspan="1">0.31</td>
                            <td align="left" colspan="1" rowspan="1">0.54</td>
                            <td align="left" colspan="1" rowspan="1">0.22</td>
                            <td align="left" colspan="1" rowspan="1">6.81×10<sup>−7</sup></td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">chr6:32773398 <italic>HLA-DQB1</italic></td>
                            <td align="left" colspan="1" rowspan="1">1.94 (1.70–2.21)</td>
                            <td align="left" colspan="1" rowspan="1">1.36 (1.21–1.52)</td>
                            <td align="left" colspan="1" rowspan="1">0.85 (0.73–1.00)</td>
                            <td align="left" colspan="1" rowspan="1">0.87 (0.66–1.14)</td>
                            <td align="left" colspan="1" rowspan="1">0.91 (0.68–1.22)</td>
                            <td align="left" colspan="1" rowspan="1">0.84 (0.64–1.12)</td>
                            <td align="left" colspan="1" rowspan="1">1.23 (1.13–1.34)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>rs2647012</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1">6.53×10<sup>−16</sup></td>
                            <td align="left" colspan="1" rowspan="1">0.36</td>
                            <td align="left" colspan="1" rowspan="1">0.12</td>
                            <td align="left" colspan="1" rowspan="1">6.34×10<sup>−4</sup></td>
                            <td align="left" colspan="1" rowspan="1">0.15</td>
                            <td align="left" colspan="1" rowspan="1">0.04</td>
                            <td align="left" colspan="1" rowspan="1">0.02</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">chr6:32772436 <italic>HLA-DQB1</italic></td>
                            <td align="left" colspan="1" rowspan="1">0.65 (0.58–0.72)</td>
                            <td align="left" colspan="1" rowspan="1">0.96 (0.88–1.05)</td>
                            <td align="left" colspan="1" rowspan="1">0.92 (0.84–1.02)</td>
                            <td align="left" colspan="1" rowspan="1">1.32 (1.13–1.55)</td>
                            <td align="left" colspan="1" rowspan="1">1.14 (0.95–1.36)</td>
                            <td align="left" colspan="1" rowspan="1">1.20 (1.01–1.41)</td>
                            <td align="left" colspan="1" rowspan="1">0.94 (0.89–0.99)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>rs6536942</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1">0.06</td>
                            <td align="left" colspan="1" rowspan="1">0.22</td>
                            <td align="left" colspan="1" rowspan="1">0.53</td>
                            <td align="left" colspan="1" rowspan="1">0.28</td>
                            <td align="left" colspan="1" rowspan="1">0.51</td>
                            <td align="left" colspan="1" rowspan="1">0.56</td>
                            <td align="left" colspan="1" rowspan="1">0.07</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">chr4:167205644 <italic>TLL1</italic></td>
                            <td align="left" colspan="1" rowspan="1">1.18 (1.00–1.40)</td>
                            <td align="left" colspan="1" rowspan="1">1.09 (0.95–1.24)</td>
                            <td align="left" colspan="1" rowspan="1">1.05 (0.90–1.22)</td>
                            <td align="left" colspan="1" rowspan="1">1.14 (0.90–1.46)</td>
                            <td align="left" colspan="1" rowspan="1">0.91 (0.68–1.22)</td>
                            <td align="left" colspan="1" rowspan="1">1.08 (0.84–1.40)</td>
                            <td align="left" colspan="1" rowspan="1">1.08 (0.99–1.18)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>rs9277554</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1">0.08</td>
                            <td align="left" colspan="1" rowspan="1">0.42</td>
                            <td align="left" colspan="1" rowspan="1">0.20</td>
                            <td align="left" colspan="1" rowspan="1">0.99</td>
                            <td align="left" colspan="1" rowspan="1">0.08</td>
                            <td align="left" colspan="1" rowspan="1">0.18</td>
                            <td align="left" colspan="1" rowspan="1">0.93</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">chr6:33163516 <italic>HLA-DPB1</italic></td>
                            <td align="left" colspan="1" rowspan="1">0.91 (0.81–1.01)</td>
                            <td align="left" colspan="1" rowspan="1">0.96 (0.87–1.06)</td>
                            <td align="left" colspan="1" rowspan="1">1.07 (0.96–1.19)</td>
                            <td align="left" colspan="1" rowspan="1">1.00 (0.84–1.19)</td>
                            <td align="left" colspan="1" rowspan="1">1.19 (0.98–1.44)</td>
                            <td align="left" colspan="1" rowspan="1">1.13 (0.94–1.36)</td>
                            <td align="left" colspan="1" rowspan="1">1.00 (0.94–1.06)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>rs441890</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1">0.91</td>
                            <td align="left" colspan="1" rowspan="1">0.14</td>
                            <td align="left" colspan="1" rowspan="1">0.74</td>
                            <td align="left" colspan="1" rowspan="1">0.47</td>
                            <td align="left" colspan="1" rowspan="1">0.63</td>
                            <td align="left" colspan="1" rowspan="1">0.95</td>
                            <td align="left" colspan="1" rowspan="1">0.37</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">chr8:71727221 <italic>LACTB2</italic></td>
                            <td align="left" colspan="1" rowspan="1">1.01 (0.90–1.13)</td>
                            <td align="left" colspan="1" rowspan="1">1.07 (0.98–1.17)</td>
                            <td align="left" colspan="1" rowspan="1">1.02 (0.92–1.12)</td>
                            <td align="left" colspan="1" rowspan="1">1.06 (0.90–1.25)</td>
                            <td align="left" colspan="1" rowspan="1">0.96 (0.80–1.15)</td>
                            <td align="left" colspan="1" rowspan="1">0.99 (0.84–1.18)</td>
                            <td align="left" colspan="1" rowspan="1">1.03 (0.97–1.09)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <bold>rs716183</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1">0.84</td>
                            <td align="left" colspan="1" rowspan="1">0.78</td>
                            <td align="left" colspan="1" rowspan="1">0.35</td>
                            <td align="left" colspan="1" rowspan="1">0.59</td>
                            <td align="left" colspan="1" rowspan="1">0.94</td>
                            <td align="left" colspan="1" rowspan="1">0.80</td>
                            <td align="left" colspan="1" rowspan="1">0.49</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">chr10:118894485<italic>VAX1</italic></td>
                            <td align="left" colspan="1" rowspan="1">0.99 (0.88–1.10)</td>
                            <td align="left" colspan="1" rowspan="1">0.99 (0.90–1.08)</td>
                            <td align="left" colspan="1" rowspan="1">0.95 (0.87–1.05)</td>
                            <td align="left" colspan="1" rowspan="1">1.05 (0.89–1.23)</td>
                            <td align="left" colspan="1" rowspan="1">1.01 (0.84–1.20)</td>
                            <td align="left" colspan="1" rowspan="1">0.98 (0.83–1.16)</td>
                            <td align="left" colspan="1" rowspan="1">0.98 (0.93–1.04)</td>
                        </tr>
                    </tbody>
                </table></alternatives><table-wrap-foot>
                    <fn id="nt107">
                        <label/>
                        <p>*Excluding SCALE1 for FL.</p>
                    </fn>
                    <fn id="nt108">
                        <label/>
                        <p>OR: odds ratio, CI: confidence interval.</p>
                    </fn>
                </table-wrap-foot></table-wrap>
        </sec>
        <sec id="s3">
            <title>Discussion</title>
            <p>Through the identification of a second variant, rs2647012, that is independent of the
                previously identified risk variant rs10484561 <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref> within the 6p21.32 region, our
                findings substantiate a major link between HLA class II loci and genetic
                susceptibility to FL. In addition, our study revealed evidence that rs10484561 is
                associated with DLBCL risk suggesting some shared biological mechanisms of
                susceptibility between these two common NHL subtypes. The association of rs2647012
                with FL risk was not detected in earlier GWAS studies <xref ref-type="bibr" rid="pgen.1001378-Skibola1">[5]</xref>, <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>, and that of rs10484561 with
                DLBCL risk previously reported was only marginal <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>, perhaps because of the smaller
                sample sizes in Stage 1. The number of FL cases scanned in this study was almost
                double compared to the previous individual GWAS <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>.</p>
            <p>HLA class II molecules are expressed in antigen presenting cells such as
                B-lymphocytes, and act to present exogenous antigens to CD4+ helper T-cells.
                Efficiency of antigen presentation may influence lymphomagenesis through effects on
                anti-tumor immunity or on immune response to infections that are directly or
                indirectly oncogenic (e.g., through viral genome insertion or nonspecific chronic
                antigenic stimulation) <xref ref-type="bibr" rid="pgen.1001378-Bateman1">[19]</xref>. Allelic variants in coding regions may affect the
                structure of the peptide binding groove of the class II molecules, leading to
                differences in the efficiency of oncogenic peptide binding or T-cell recognition.
                Coding sequence variation in the molecules encoded by the extended
                    <italic>HLA-DRB1*0101-HLA-DQA1*0101-HLA-DQB1*0501</italic> haplotype
                may be responsible for the association at rs10484561 <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>.</p>
            <p>Alternatively, variants in the regulatory sequences may influence the expression
                level of the HLA molecules and consequently the efficiency of antigen presentation.
                We note that rs2647012 is strongly associated with the average expression levels of
                    <italic>HLA-DRB4</italic> (β = 0.78,
                    P = 3.4×10<sup>-22</sup>) and
                    <italic>HLA-DQA1</italic> (β = -0.58,
                    P = 5.1×10<sup>−13</sup>) probes in
                Epstein-Barr virus-transfected lymphoblastoid cell lines (mRNA by SNP browser) <xref ref-type="bibr" rid="pgen.1001378-Dixon1">[20]</xref>, and rs10484561
                is also associated with the expression levels of <italic>HLA-DQA1</italic> probes
                (β = -0.884,
                    P = 1.6×10<sup>−10</sup>). We speculate that
                this may be an alternative mechanism underlying the observed associations,
                especially at rs2647012.</p>
            <p>Interestingly, SNPs within the same LD block harboring rs2647012
                (r<sup>2</sup>&gt;0.7 in HapMap CEU) have previously been associated with rheumatoid
                arthritis with the same direction of effect <xref ref-type="bibr" rid="pgen.1001378-Plenge1">[21]</xref>. Since autoimmune disorders
                such as rheumatoid arthritis and Sjögren syndrome are associated with increased
                risk of NHL, in particular with DLBCL but also with FL <xref ref-type="bibr" rid="pgen.1001378-Baecklund1">[22]</xref>, our finding may suggest a
                molecular link between these diseases, although their associations within this
                region of high LD could also be due to different causal variants.</p>
            <p>Previously, large-scale candidate gene studies have pointed to susceptibility loci in
                the HLA class III region mainly between the <italic>TNF</italic> variant
                    <italic>–</italic>308G-&gt;A (rs1800629) and risk of DLBCL <xref ref-type="bibr" rid="pgen.1001378-Rothman1">[23]</xref>, <xref ref-type="bibr" rid="pgen.1001378-Skibola2">[24]</xref>. We provide
                novel evidence of association of DLBCL with an independent HLA marker in the class
                II region (rs10484561; r<sup>2</sup> = 0), 1.1Mb away from
                rs1800629, strongly suggesting that alleles in the HLA class II region may play an
                important role in the pathogenesis of this subtype as well. The weaker association
                of rs10484561 with DLBCL (OR 1.36) than with FL (OR 1.95) <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref> could imply that the
                DLBCL-association is confined to a subset of DLBCL tumors with specific
                morphological or molecular features more closely related to FL, such as the germinal
                center-like B-cell phenotype <xref ref-type="bibr" rid="pgen.1001378-Alizadeh1">[25]</xref>. However, the observed effects could also be due to
                modification of other concurrent DLBCL-specific susceptibility variants, or
                rs10484561 could tag a more strongly associated marker in this region of high
                LD.</p>
            <p>Moreover, we found suggestive evidence of association at rs6536942 on 4q32.3, located
                within an intron of the tolloid-like 1 (<italic>TLL1</italic>) gene, with FL risk.
                However, larger studies are needed to validate this finding. Although the strongest
                associations so far have been observed in the HLA region, and extended pooling of
                available scan data failed to identify additional loci outside of HLA, we expect
                that future larger meta-GWAS efforts will more robustly identify additional loci in
                other regions.</p>
            <p>In conclusion, our results strongly suggest that future genetic and functional work
                focused on the HLA class II region will provide important insight into the disease
                pathology of FL, DLBCL and other subtypes of NHL. In addition, further studies of
                this region and potential interaction with environmental factors in NHL risk, and of
                NHL prognosis are warranted.</p>
        </sec>
        <sec id="s4" sec-type="methods">
            <title>Methods</title>
            <sec id="s4a">
                <title>Ethics statement</title>
                <p>The studies described in this manuscript have been approved by the ethics
                    committee of the respective institutions: Karolinska Institutet (Sweden),
                    Scientific Ethics Committee system (Denmark), University of California, Berkeley
                    (US), National Cancer Institute, National Institutes of Health (US), Mayo Clinic
                    (US), University of British Columbia (Canada), Yale University (US), University
                    of Sydney (Australia).</p>
            </sec>
            <sec id="s4b">
                <title>Study subjects</title>
                <p>The SCALE study is a population-based study of the etiology of NHL carried out in
                    all of Denmark and Sweden during 1999 to 2002 <xref ref-type="bibr" rid="pgen.1001378-Smedby1">[26]</xref>. NHL subtype diagnoses were
                    reviewed and reclassified according to the World Health Organization (WHO)
                    classification <xref ref-type="bibr" rid="pgen.1001378-Jaffe1">[1]</xref> as previously described <xref ref-type="bibr" rid="pgen.1001378-Smedby1">[26]</xref>. For this GWAS (SCALE1) we
                    used DNA from 400 cases with follicular lymphoma (FL; 150 from Denmark and 250
                    from Sweden) and from 150 Danish controls, individually matched to the Danish FL
                    cases by sex and age at study inclusion. We also used material collected from
                    673 control subjects in a separate Swedish population-based case-control study
                    of rheumatoid arthritis (the Eira study) <xref ref-type="bibr" rid="pgen.1001378-Plenge1">[21]</xref>, <xref ref-type="bibr" rid="pgen.1001378-Plenge2">[27]</xref>. The latter was conducted
                    during 1996 to 2005 among residents 18 to 70 years of age in the southern and
                    central parts of Sweden (including 90% of Swedish residents). Hence, the
                    population controls recruited in this study were considered to represent the
                    same study population as the Swedish component of the SCALE study with regard to
                    genetic variation. Genotyping completion rates were similar between cases and
                    controls; out of 400 cases and 823 controls genotyped, 379 cases (95%)
                    and 791 controls (96%) were included in the final analysis. Study
                    subjects used in Stages 2, 3 and validation in other NHL subtypes (<xref ref-type="table" rid="pgen-1001378-t001">Table 1</xref>, <xref ref-type="supplementary-material" rid="pgen.1001378.s007">Table S1</xref>,
                        <xref ref-type="supplementary-material" rid="pgen.1001378.s008">S2</xref>)
                    have been previously described <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>, <xref ref-type="bibr" rid="pgen.1001378-Cerhan1">[8]</xref>–<xref ref-type="bibr" rid="pgen.1001378-Spinelli1">[12]</xref>, and details are
                    available as supporting text (<xref ref-type="supplementary-material" rid="pgen.1001378.s018">Text S1</xref>). For the SCALE2 NHL subtype
                    validation study, we used the rest of the lymphoma cases with blood samples
                    originally recruited in SCALE (n = 1869), Danish control
                    subjects not included in the GWAS (n = 556), a second set
                    of control subjects from the Eira study (n = 742) and a
                    third group of controls recruited in a national population-based case-control
                    study of breast cancer, the Cancer and Hormones Replacement in Sweden (CAHRES)
                    study <xref ref-type="bibr" rid="pgen.1001378-Magnusson1">[28]</xref>
                    (n = 720). The control subjects from this study were
                    randomly selected from the Swedish general population to match the expected age
                    distribution of the participating breast cancer cases (50 to 74 years).</p>
            </sec>
            <sec id="s4c">
                <title>Genotyping</title>
                <p>Stage I genotyping of 317,503 single nucleotide polymorphisms (SNPs) was done on
                    the HumanHap300 (version 1.0) array. Validation genotyping was done using
                    Sequenom iPlex; SNPs in the human leukocyte antigen (HLA) region that failed
                    primer design for Sequenom assays were genotyped using Taqman (Applied
                    Biosystems).</p>
            </sec>
            <sec id="s4d">
                <title>Genome-wide association study</title>
                <p>The scan included 317,503 SNPs from the HumanHap300 (version 1.0) array. The
                    datasets were filtered on the basis of SNP genotyping call rates
                    (≥&gt;95% completeness), sample completion rate (≥90%),
                    minor allele frequency (MAF; all subjects as well as cases and controls
                    separately ≥0.03) and non-deviation from Hardy-Weinberg equilibrium (HWE;
                        p&lt;10<sup>−6</sup>). We also excluded SNPs with cluster plot
                    problems, and those on the X and Y chromosomes. Study subjects with gender
                    discrepancies and/or labelling errors were removed. We also removed individual
                    samples with evidence of cryptic family relationships (identified using
                    the–genome command in PLINK). To detect outliers in terms of population
                    stratification, we performed principal component (PC) analysis using the
                    EIGENSTRAT software (<xref ref-type="supplementary-material" rid="pgen.1001378.s004">Figure S4</xref>). A subset of linkage
                    disequilibrium (LD) thinned SNPs was selected such that all pair-wise
                    associations had r<sup>2</sup>&lt;0.2, and long-range regions of high LD,
                    reported to potentially confound genome scans, were removed <xref ref-type="bibr" rid="pgen.1001378-Price1">[29]</xref>. Twenty-five
                    samples were removed as population outliers on the basis of their values on the
                    first three PCs. To adjust for possible stratification in our association
                    analyses we adjusted the regression analyses using the first three PCs; the
                    number of PCs used for adjustment was determined by plotting the eigenvalues and
                    locating the position of the “elbow” on the scree plot (<xref ref-type="supplementary-material" rid="pgen.1001378.s005">Figure S5</xref>).
                    Wald tests, treating minor allele counts as continuous covariates were used to
                    test for association. The genomic inflation factor (λ) was calculated to be
                    1.0283 after adjusting for the first three PCs, suggesting the presence of
                    minimal stratification. Quantile-quantile plots for the associations before and
                    after adjustment are shown in <xref ref-type="supplementary-material" rid="pgen.1001378.s006">Figure S6</xref>. Finally, we assessed associations
                    of age and sex with main genotypes among the control subjects to address the
                    possibility of confounding by these factors (<xref ref-type="supplementary-material" rid="pgen.1001378.s017">Table S11</xref>).
                    As there was no evidence of associations of age or sex with genotypes among the
                    controls, we did not adjust for them in the final main effects analyses of
                    genotypes.</p>
            </sec>
            <sec id="s4e">
                <title>Validation and meta-analysis</title>
                <p>In Stage 2, similar quality control measures were applied as in Stage 1,
                    including genotyping call rate ≥95%, sample completion rate
                    ≥90%, and MAF ≥0.05. We tested each validation study for
                    association using trend tests. For meta-analyses across studies and NHL
                    subtypes, we used the Cochran-Mantel-Haenszel method to calculate the combined
                    odds ratio and P-value, and χ<sup>2</sup> tests for heterogeneity.
                    Multivariate logistic regression was used to test for independence of SNP
                    effects. For validation among other NHL subtypes, the control subjects were the
                    same as those in Stages 2 and 3 for validation in FL for all studies except
                    SCALE2. Only European-ancestry subjects were included, and the possibility of
                    population stratification affecting the results has been thoroughly explored and
                    found to be low in earlier investigations in the same populations <xref ref-type="bibr" rid="pgen.1001378-Conde1">[6]</xref>, <xref ref-type="bibr" rid="pgen.1001378-Cerhan1">[8]</xref>.</p>
            </sec>
            <sec id="s4f">
                <title>Imputation</title>
                <p>We used IMPUTEv1 for the imputation of SNPs from the 1000 Genomes pilot1 CEU data
                    (August 2009 release); and the HapMap Phase II release 22 CEU data. We set a
                    strict threshold for imputation, using only SNPs with confidence scores of
                    ≥0.9, call rates ≥90%, non-deviation from Hardy-Weinberg
                    equilibrium P &gt;0.001 and MAF &gt;0.01. The imputation was done on the Stage 1
                    samples separately for each of the two reference datasets and SNPs showing a
                    discordance of &gt;5% between the genotypes imputed with the two datasets
                    were excluded from further analysis. The data were then merged using HapMap II
                    as the master dataset to which additional imputed SNPs from the 1000 Genomes
                    dataset were added. HLA alleles were imputed by identifying tag SNPs <xref ref-type="bibr" rid="pgen.1001378-deBakker2">[15]</xref> from the
                    genotyped and imputed SNP dataset. We used PLINK for haplotype imputation with
                    the tag SNPs and downstream association analyses. Only haplotypes with call
                    rates &gt;90%, MAF&gt;1% and probability thresholds &gt;0.8 were
                    analyzed.</p>
            </sec>
            <sec id="s4g">
                <title>Haplotype and coalescence analyses</title>
                <p>For coalescence analysis all 12 SNPs (genotyped in this study and within a region
                    of ∼177 Kb) adjacent to the two SNPs associated with the FL risk were used
                    to construct haplotypes. These were phased using the PHASE program <xref ref-type="bibr" rid="pgen.1001378-Stephens1">[30]</xref> and
                    tested for association using PLINK. The ancestral haplotype was constructed from
                    the chimpanzee (PanTro2) allele whenever possible, and otherwise from the
                    macaque alleles. An ancestral recombination graph was constructed using the
                    program Beagle <xref ref-type="bibr" rid="pgen.1001378-Song1">[13]</xref>, <xref ref-type="bibr" rid="pgen.1001378-Lyngs1">[31]</xref> which allows recombination assuming an infinite site
                    mutation model. After identifying the first recombination event the haplotype
                    segment before the recombination spot was used to construct a median
                    –joining network using the Network program <xref ref-type="bibr" rid="pgen.1001378-Bandelt1">[14]</xref>. The alleles of the
                    imputed SNP rs9378212 were then phased on each haplotype segment using the PHASE
                    program.</p>
                <p>The URLs for the data and analytic approaches presented herein are as
                    follows:</p>
                <p>1000 Genomes <ext-link ext-link-type="uri" xlink:href="http://1000genomes.org" xlink:type="simple">http://1000genomes.org</ext-link></p>
                <p>HapMapII <ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org" xlink:type="simple">http://www.hapmap.org</ext-link></p>
                <p>IMPUTEv1 <ext-link ext-link-type="uri" xlink:href="https://mathgen.stats.ox.ac.uk/impute/impute_v1.html" xlink:type="simple">https://mathgen.stats.ox.ac.uk/impute/impute_v1.html</ext-link></p>
                <p>mRNA by SNP browser <ext-link ext-link-type="uri" xlink:href="http://www.sph.umich.edu/csg/liang/asthma/" xlink:type="simple">http://www.sph.umich.edu/csg/liang/asthma/</ext-link></p>
                <p>R script for recombination plot <ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/science/projects/diabetes-genetics-initiative/plotting-genome-wide-association-results" xlink:type="simple">http://www.broadinstitute.org/science/projects/diabetes-genetics-initiative/plotting-genome-wide-association-results</ext-link></p>
            </sec>
        </sec>
        <sec id="s5">
            <title>Supporting Information</title>
            <supplementary-material id="pgen.1001378.s001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s001" xlink:type="simple">
                <label>Figure S1</label>
                <caption>
                    <p>Forest plots of main associations with risk of follicular lymphoma (FL) and
                        diffuse large B-cell lymphoma (DLBCL).</p>
                    <p>(0.18 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s002" xlink:type="simple">
                <label>Figure S2</label>
                <caption>
                    <p>Association results for imputed SNPs and genotyped SNPs.</p>
                    <p>(0.03 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s003" xlink:type="simple">
                <label>Figure S3</label>
                <caption>
                    <p>Ancestral reconstruction graph based on the 14 SNPs in the Stage 1
                        samples.</p>
                    <p>(0.05 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s004" xlink:type="simple">
                <label>Figure S4</label>
                <caption>
                    <p>Testing of population structure using principal components analysis.</p>
                    <p>(0.11 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s005" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s005" xlink:type="simple">
                <label>Figure S5</label>
                <caption>
                    <p>Principal components analysis scree plot.</p>
                    <p>(0.02 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s006" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s006" xlink:type="simple">
                <label>Figure S6</label>
                <caption>
                    <p>Quantile-quantile plots before and after genomic control correction.</p>
                    <p>(0.07 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s007" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s007" xlink:type="simple">
                <label>Table S1</label>
                <caption>
                    <p>Number of patients with Non-Hodgkin lymphoma subtypes other than follicular
                        lymphoma.</p>
                    <p>(0.01 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s008" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s008" xlink:type="simple">
                <label>Table S2</label>
                <caption>
                    <p>Overlap of samples from the current genome-wide association study and the
                        previous GWAS reporting association between 6p21.32 and follicular lymphoma
                        risk.</p>
                    <p>(0.01 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s009" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s009" xlink:type="simple">
                <label>Table S3</label>
                <caption>
                    <p>Top 40 SNPs taken forward to Stage 2, sorted by significance level (trend
                        P-value) of association with risk of follicular lymphoma.</p>
                    <p>(0.02 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s010" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s010" xlink:type="simple">
                <label>Table S4</label>
                <caption>
                    <p>SNPs on chromosome 6p21.32 that showed genome-wide per allele P-values &lt;
                        1E-04 in association with risk of follicular lymphoma in Stage 1, sorted by
                        position.</p>
                    <p>(0.01 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s011" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s011" xlink:type="simple">
                <label>Table S5</label>
                <caption>
                    <p>Summary statistics for associations with risk of follicular lymphoma in
                        Stages 1 and 2 with combined P-values.</p>
                    <p>(0.02 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s012" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s012" xlink:type="simple">
                <label>Table S6</label>
                <caption>
                    <p>Crude and adjusted logistic regression analyses of the six SNPs in 6p21.32
                        showing significant association with risk of follicular lymphoma in Stages 1
                        and 2.</p>
                    <p>(0.01 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s013" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s013" xlink:type="simple">
                <label>Table S7</label>
                <caption>
                    <p>Individual study results for associations between the 5 SNPs taken forward to
                        Stage 3 and risk of follicular lymphoma in Stage 3.</p>
                    <p>(0.01 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s014" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s014" xlink:type="simple">
                <label>Table S8</label>
                <caption>
                    <p>Genotype counts of main SNPs per Cases/Controls, per study and in total.</p>
                    <p>(0.01 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s015" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s015" xlink:type="simple">
                <label>Table S9</label>
                <caption>
                    <p>Associations with risk of follicular lymphoma for haplotypes phased with 14
                        SNPs or 7 SNPs based on genotyped SNPs in Stage 1.</p>
                    <p>(0.01 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s016" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s016" xlink:type="simple">
                <label>Table S10</label>
                <caption>
                    <p>Imputation of HLA class II alleles and risk of follicular lymphoma.</p>
                    <p>(0.01 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s017" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s017" xlink:type="simple">
                <label>Table S11</label>
                <caption>
                    <p>Trend p-value of associations of age and sex with main genotypes among
                        controls subjects per study.</p>
                    <p>(0.02 MB PDF)</p>
                </caption>
            </supplementary-material>
            <supplementary-material id="pgen.1001378.s018" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.1001378.s018" xlink:type="simple">
                <label>Text S1</label>
                <caption>
                    <p>Additional description of validation study subjects.</p>
                    <p>(0.04 MB PDF)</p>
                </caption>
            </supplementary-material>
        </sec>
    </body>
    <back>
        <ack>
            <p>We are grateful to X. Y. Chen, H. B. Toh, K. K. Heng, W. Y. Meah, C. H. Wong, and H.
                Q. Low from the Genome Institute of Singapore for their support in genotyping
                analyses and data processing for the SCALE study. The control samples from the
                CAHRES study were provided by Per Hall and Kamila Czene.</p>
        </ack>
        <ref-list>
            <title>References</title>
            <ref id="pgen.1001378-Jaffe1">
                <label>1</label>
                <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Jaffe</surname>
                            <given-names>ES</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Harris</surname>
                            <given-names>NL</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Stein</surname>
                            <given-names>H</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Vardiman</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>
                    <year>2001</year>
                    <article-title>World Health Organization classification of tumours pathology and
                        genetics, tumours of hematopoietic and lymphoid tissues.</article-title>
                    <publisher-loc>Lyon</publisher-loc>
                    <publisher-name>IARC Press</publisher-name>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Morton1">
                <label>2</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Morton</surname>
                            <given-names>LM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>SS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Cozen</surname>
                            <given-names>W</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Linet</surname>
                            <given-names>MS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Chatterjee</surname>
                            <given-names>N</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2008</year>
                    <article-title>Etiologic heterogeneity among non-Hodgkin lymphoma
                        subtypes.</article-title>
                    <source>Blood</source>
                    <volume>112</volume>
                    <fpage>5150</fpage>
                    <lpage>5160</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Altieri1">
                <label>3</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Altieri</surname>
                            <given-names>A</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Bermejo</surname>
                            <given-names>JL</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Hemminki</surname>
                            <given-names>K</given-names>
                        </name>
                    </person-group>
                    <year>2005</year>
                    <article-title>Familial risk for non-Hodgkin lymphoma and other
                        lymphoproliferative malignancies by histopathologic subtype: the Swedish
                        Family-Cancer Database.</article-title>
                    <source>Blood</source>
                    <volume>106</volume>
                    <fpage>668</fpage>
                    <lpage>672</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Chang1">
                <label>4</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Chang</surname>
                            <given-names>ET</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Smedby</surname>
                            <given-names>KE</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Hjalgrim</surname>
                            <given-names>H</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Glimelius</surname>
                            <given-names>B</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Adami</surname>
                            <given-names>HO</given-names>
                        </name>
                    </person-group>
                    <year>2006</year>
                    <article-title>Reliability of self-reported family history of cancer in a large
                        case-control study of lymphoma.</article-title>
                    <source>J Natl Cancer Inst</source>
                    <volume>98</volume>
                    <fpage>61</fpage>
                    <lpage>68</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Skibola1">
                <label>5</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Skibola</surname>
                            <given-names>CF</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Bracci</surname>
                            <given-names>PM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Halperin</surname>
                            <given-names>E</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Conde</surname>
                            <given-names>L</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Craig</surname>
                            <given-names>DW</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2009</year>
                    <article-title>Genetic variants at 6p21.33 are associated with susceptibility to
                        follicular lymphoma.</article-title>
                    <source>Nat Genet</source>
                    <volume>41</volume>
                    <fpage>873</fpage>
                    <lpage>875</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Conde1">
                <label>6</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Conde</surname>
                            <given-names>L</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Halperin</surname>
                            <given-names>E</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Brown</surname>
                            <given-names>KM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Smedby</surname>
                            <given-names>KE</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Rothman</surname>
                            <given-names>N</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2010</year>
                    <article-title>Genome-wide association study of follicular lymphoma identifies a
                        risk locus at 6p21.32.</article-title>
                    <source>Nat Genet</source>
                    <volume>42</volume>
                    <fpage>661</fpage>
                    <lpage>664</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-deBakker1">
                <label>7</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>de Bakker</surname>
                            <given-names>PI</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Ferreira</surname>
                            <given-names>MA</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Jia</surname>
                            <given-names>X</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Neale</surname>
                            <given-names>BM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Raychaudhuri</surname>
                            <given-names>S</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2008</year>
                    <article-title>Practical aspects of imputation-driven meta-analysis of
                        genome-wide association studies.</article-title>
                    <source>Hum Mol Genet</source>
                    <volume>17</volume>
                    <fpage>R122</fpage>
                    <lpage>128</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Cerhan1">
                <label>8</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Cerhan</surname>
                            <given-names>JR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Ansell</surname>
                            <given-names>SM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Fredericksen</surname>
                            <given-names>ZS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Kay</surname>
                            <given-names>NE</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Liebow</surname>
                            <given-names>M</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2007</year>
                    <article-title>Genetic variation in 1253 immune and inflammation genes and risk
                        of non-Hodgkin lymphoma.</article-title>
                    <source>Blood</source>
                    <volume>110</volume>
                    <fpage>4455</fpage>
                    <lpage>4463</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Wang1">
                <label>9</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>SS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Cerhan</surname>
                            <given-names>JR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Hartge</surname>
                            <given-names>P</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Davis</surname>
                            <given-names>S</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Cozen</surname>
                            <given-names>W</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2006</year>
                    <article-title>Common genetic variants in proinflammatory and other
                        immunoregulatory genes and risk for non-Hodgkin lymphoma.</article-title>
                    <source>Cancer Res</source>
                    <volume>66</volume>
                    <fpage>9771</fpage>
                    <lpage>9780</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Zhang1">
                <label>10</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Zhang</surname>
                            <given-names>Y</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Holford</surname>
                            <given-names>TR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Leaderer</surname>
                            <given-names>B</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Boyle</surname>
                            <given-names>P</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Zahm</surname>
                            <given-names>SH</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2004</year>
                    <article-title>Hair-coloring product use and risk of non-Hodgkin's
                        lymphoma: a population-based case-control study in
                        Connecticut.</article-title>
                    <source>Am J Epidemiol</source>
                    <volume>159</volume>
                    <fpage>148</fpage>
                    <lpage>154</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Hughes1">
                <label>11</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Hughes</surname>
                            <given-names>AM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Armstrong</surname>
                            <given-names>BK</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Vajdic</surname>
                            <given-names>CM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Turner</surname>
                            <given-names>J</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Grulich</surname>
                            <given-names>A</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2004</year>
                    <article-title>Pigmentary characteristics, sun sensitivity and non-Hodgkin
                        lymphoma.</article-title>
                    <source>Int J Cancer</source>
                    <volume>110</volume>
                    <fpage>429</fpage>
                    <lpage>434</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Spinelli1">
                <label>12</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Spinelli</surname>
                            <given-names>JJ</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Ng</surname>
                            <given-names>CH</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Weber</surname>
                            <given-names>JP</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Connors</surname>
                            <given-names>JM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Gascoyne</surname>
                            <given-names>RD</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2007</year>
                    <article-title>Organochlorines and risk of non-Hodgkin lymphoma.</article-title>
                    <source>Int J Cancer</source>
                    <volume>121</volume>
                    <fpage>2767</fpage>
                    <lpage>2775</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Song1">
                <label>13</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Song</surname>
                            <given-names>YS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Hein</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>
                    <year>2005</year>
                    <article-title>Constructing minimal ancestral recombination
                        graphs.</article-title>
                    <source>J Comput Biol</source>
                    <volume>12</volume>
                    <fpage>147</fpage>
                    <lpage>169</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Bandelt1">
                <label>14</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Bandelt</surname>
                            <given-names>HJ</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Forster</surname>
                            <given-names>P</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Rohl</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>
                    <year>1999</year>
                    <article-title>Median-joining networks for inferring intraspecific
                        phylogenies.</article-title>
                    <source>Mol Biol Evol</source>
                    <volume>16</volume>
                    <fpage>37</fpage>
                    <lpage>48</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-deBakker2">
                <label>15</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>de Bakker</surname>
                            <given-names>PI</given-names>
                        </name>
                        <name name-style="western">
                            <surname>McVean</surname>
                            <given-names>G</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Sabeti</surname>
                            <given-names>PC</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Miretti</surname>
                            <given-names>MM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Green</surname>
                            <given-names>T</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2006</year>
                    <article-title>A high-resolution HLA and SNP haplotype map for disease
                        association studies in the extended human MHC.</article-title>
                    <source>Nat Genet</source>
                    <volume>38</volume>
                    <fpage>1166</fpage>
                    <lpage>1172</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Leslie1">
                <label>16</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Leslie</surname>
                            <given-names>S</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Donnelly</surname>
                            <given-names>P</given-names>
                        </name>
                        <name name-style="western">
                            <surname>McVean</surname>
                            <given-names>G</given-names>
                        </name>
                    </person-group>
                    <year>2008</year>
                    <article-title>A statistical method for predicting classical HLA alleles from
                        SNP data.</article-title>
                    <source>Am J Hum Genet</source>
                    <volume>82</volume>
                    <fpage>48</fpage>
                    <lpage>56</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Wang2">
                <label>17</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>SS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Abdou</surname>
                            <given-names>AM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Morton</surname>
                            <given-names>LM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Thomas</surname>
                            <given-names>R</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Cerhan</surname>
                            <given-names>JR</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2010</year>
                    <article-title>Human leukocyte antigen class I and II alleles in non-Hodgkin
                        lymphoma etiology.</article-title>
                    <source>Blood</source>
                    <volume>115</volume>
                    <fpage>4820</fpage>
                    <lpage>4823</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Abdou1">
                <label>18</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Abdou</surname>
                            <given-names>AM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Gao</surname>
                            <given-names>X</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Cozen</surname>
                            <given-names>W</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Cerhan</surname>
                            <given-names>JR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Rothman</surname>
                            <given-names>N</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2010</year>
                    <article-title>Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor
                        necrosis factor (TNF) G-308A, and risk of non-Hodgkin
                        lymphoma.</article-title>
                    <source>Leukemia</source>
                    <volume>24</volume>
                    <fpage>1055</fpage>
                    <lpage>1058</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Bateman1">
                <label>19</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Bateman</surname>
                            <given-names>AC</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Howell</surname>
                            <given-names>WM</given-names>
                        </name>
                    </person-group>
                    <year>1999</year>
                    <article-title>Human leukocyte antigens and cancer: is it in our
                        genes?</article-title>
                    <source>J Pathol</source>
                    <volume>188</volume>
                    <fpage>231</fpage>
                    <lpage>236</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Dixon1">
                <label>20</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Dixon</surname>
                            <given-names>AL</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Liang</surname>
                            <given-names>L</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Moffatt</surname>
                            <given-names>MF</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>W</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Heath</surname>
                            <given-names>S</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2007</year>
                    <article-title>A genome-wide association study of global gene
                        expression.</article-title>
                    <source>Nat Genet</source>
                    <volume>39</volume>
                    <fpage>1202</fpage>
                    <lpage>1207</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Plenge1">
                <label>21</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Plenge</surname>
                            <given-names>RM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Seielstad</surname>
                            <given-names>M</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Padyukov</surname>
                            <given-names>L</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Lee</surname>
                            <given-names>AT</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Remmers</surname>
                            <given-names>EF</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2007</year>
                    <article-title>TRAF1-C5 as a risk locus for rheumatoid arthritis–a
                        genomewide study.</article-title>
                    <source>N Engl J Med</source>
                    <volume>357</volume>
                    <fpage>1199</fpage>
                    <lpage>1209</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Baecklund1">
                <label>22</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Baecklund</surname>
                            <given-names>E</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Backlin</surname>
                            <given-names>C</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Iliadou</surname>
                            <given-names>A</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Granath</surname>
                            <given-names>F</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Ekbom</surname>
                            <given-names>A</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2006</year>
                    <article-title>Characteristics of diffuse large B cell lymphomas in rheumatoid
                        arthritis.</article-title>
                    <source>Arthritis Rheum</source>
                    <volume>54</volume>
                    <fpage>3774</fpage>
                    <lpage>3781</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Rothman1">
                <label>23</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Rothman</surname>
                            <given-names>N</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Skibola</surname>
                            <given-names>CF</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>SS</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Morgan</surname>
                            <given-names>G</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Lan</surname>
                            <given-names>Q</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2006</year>
                    <article-title>Genetic variation in TNF and IL10 and risk of non-Hodgkin
                        lymphoma: a report from the InterLymph Consortium.</article-title>
                    <source>Lancet Oncol</source>
                    <volume>7</volume>
                    <fpage>27</fpage>
                    <lpage>38</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Skibola2">
                <label>24</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Skibola</surname>
                            <given-names>CF</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Bracci</surname>
                            <given-names>PM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Nieters</surname>
                            <given-names>A</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Brooks-Wilson</surname>
                            <given-names>A</given-names>
                        </name>
                        <name name-style="western">
                            <surname>de Sanjose</surname>
                            <given-names>S</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2010</year>
                    <article-title>Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA)
                        polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph
                        Consortium.</article-title>
                    <source>Am J Epidemiol</source>
                    <volume>171</volume>
                    <fpage>267</fpage>
                    <lpage>276</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Alizadeh1">
                <label>25</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Alizadeh</surname>
                            <given-names>AA</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Eisen</surname>
                            <given-names>MB</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Davis</surname>
                            <given-names>RE</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Ma</surname>
                            <given-names>C</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Lossos</surname>
                            <given-names>IS</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2000</year>
                    <article-title>Distinct types of diffuse large B-cell lymphoma identified by
                        gene expression profiling.</article-title>
                    <source>Nature</source>
                    <volume>403</volume>
                    <fpage>503</fpage>
                    <lpage>511</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Smedby1">
                <label>26</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Smedby</surname>
                            <given-names>KE</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Hjalgrim</surname>
                            <given-names>H</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Melbye</surname>
                            <given-names>M</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Torrang</surname>
                            <given-names>A</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Rostgaard</surname>
                            <given-names>K</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2005</year>
                    <article-title>Ultraviolet radiation exposure and risk of malignant
                        lymphomas.</article-title>
                    <source>J Natl Cancer Inst</source>
                    <volume>97</volume>
                    <fpage>199</fpage>
                    <lpage>209</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Plenge2">
                <label>27</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Plenge</surname>
                            <given-names>RM</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Padyukov</surname>
                            <given-names>L</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Remmers</surname>
                            <given-names>EF</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Purcell</surname>
                            <given-names>S</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Lee</surname>
                            <given-names>AT</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2005</year>
                    <article-title>Replication of putative candidate-gene associations with
                        rheumatoid arthritis in &gt;4,000 samples from North America and Sweden:
                        association of susceptibility with PTPN22, CTLA4, and PADI4.</article-title>
                    <source>Am J Hum Genet</source>
                    <volume>77</volume>
                    <fpage>1044</fpage>
                    <lpage>1060</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Magnusson1">
                <label>28</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Magnusson</surname>
                            <given-names>C</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Baron</surname>
                            <given-names>J</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Persson</surname>
                            <given-names>I</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Wolk</surname>
                            <given-names>A</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Bergstrom</surname>
                            <given-names>R</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>1998</year>
                    <article-title>Body size in different periods of life and breast cancer risk in
                        post-menopausal women.</article-title>
                    <source>Int J Cancer</source>
                    <volume>76</volume>
                    <fpage>29</fpage>
                    <lpage>34</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Price1">
                <label>29</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Price</surname>
                            <given-names>AL</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Weale</surname>
                            <given-names>ME</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Patterson</surname>
                            <given-names>N</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Myers</surname>
                            <given-names>SR</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Need</surname>
                            <given-names>AC</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <year>2008</year>
                    <article-title>Long-range LD can confound genome scans in admixed
                        populations.</article-title>
                    <source>Am J Hum Genet</source>
                    <volume>83</volume>
                    <fpage>132</fpage>
                    <lpage>135; author reply 135-139</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Stephens1">
                <label>30</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Stephens</surname>
                            <given-names>M</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Smith</surname>
                            <given-names>NJ</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Donnelly</surname>
                            <given-names>P</given-names>
                        </name>
                    </person-group>
                    <year>2001</year>
                    <article-title>A new statistical method for haplotype reconstruction from
                        population data.</article-title>
                    <source>Am J Hum Genet</source>
                    <volume>68</volume>
                    <fpage>978</fpage>
                    <lpage>989</lpage>
                </element-citation>
            </ref>
            <ref id="pgen.1001378-Lyngs1">
                <label>31</label>
                <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author">
                        <name name-style="western">
                            <surname>Lyngsø</surname>
                            <given-names>R</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Song</surname>
                            <given-names>Y</given-names>
                        </name>
                        <name name-style="western">
                            <surname>Hein</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>
                    <year>2005</year>
                    <article-title>Minimum recombination histories by branch and bound, proceedings
                        of workshop on algorithms in bioinformatics.</article-title>
                    <source>Lect Notes Comput Sci</source>
                    <volume>3692</volume>
                    <fpage>239</fpage>
                    <lpage>250</lpage>
                </element-citation>
            </ref>
        </ref-list>
        
    </back>
</article>